Clinical Trial Update: Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating two antiretroviral regimens in HIV-infected pregnant women starting ART late in pregnancy to prevent mother-to-child transmiss…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV in Pregnancy

Snippet

Sponsor: Westat | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2019-12-26